Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma

British Journal of Haematology

Volumn 143, Issue 3, 2008, Pages 374-377

  Vari, F ^a   Munster, D J ^a   Hsu, J L ^a   Rossetti, T R ^a   Mahler, S M ^a   Gray, P P ^a   Turtle, C J ^a,c   Prue, R L ^a   Hart, D N J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c USA   (United States)

Author keywords

Blood dendritic cells; Cancer vaccine; Immunomagnetic separation; Immunotherapy; Multiple myeloma

Indexed keywords

CMRF 56 MONOCLONAL ANTIBODY; DENDRITIC CELL VACCINE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BIOPROCESS; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL CULTURE; CELL LABELING; CELL POPULATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; BIOTINYLATION; CANCER VACCINES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; MULTIPLE MYELOMA; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 54049098021     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07346.x     Document Type: Article

References (12)

1. Aranha-Creado, H., Peterson, J. Huang, P.Y. (1998) Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter. Biologicals, 26, 167 172.
2. Bos, O.J., Sunye, D.G., Nieuweboer, C.E., van Engelenburg, F.A., Schuitemaker, H. Over, J. (1998) Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process. Biologicals, 26, 267 276.
3. Curti, A., Tosi, P., Comoli, P., Terragna, C., Ferri, E., Cellini, C., Massaia, M., D'Addio, A., Giudice, V., Di Bello, C., Cavo, M., Conte, R., Gugliotta, G., Baccarani, M. Lemoli, R.M. (2007) Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. British Journal of Haematology, 139, 415 424.
4. Freeman, J.L., Vari, F. Hart, D.N. (2007) CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses. Journal of Immunotherapy, 30, 740 748.
5. Gould, P. (2006) Sipuleucel-T shows partial advantage in prostate cancer. The Lancet Oncology, 7, 710.
6. Hock, B.D., Fearnley, D.B., Boyce, A., McLellan, A.D., Sorg, R.V., Summers, K.L. Hart, D.N. (1999) Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens, 53, 320 334.
7. Jalili, A., Ozaki, S., Hara, T., Shibata, H., Hashimoto, T., Abe, M., Nishioka, Y. Matsumoto, T. (2005) Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma. Blood, 106, 3538 3545.
8. Lopez, J.A., Bioley, G., Turtle, C.J., Pinzon-Charry, A., Ho, C.S., Vuckovic, S., Crosbie, G., Gilleece, M., Jackson, D.C., Munster, D. Hart, D.N.J. (2003) Single Step isolation of blood dendritic cells by positive immunoselection. Journal of Immunological Methods, 274, 47 61.
9. Radford, K.J., Vari, F. Hart, D.N. (2005) Vaccine strategies to treat lymphoproliferative disorders. Pathology, 37, 534 550.
10. Strobeck, M. (2007) Multiple myeloma therapies. Nature Reviews. Drug Discovery, 6, 181 182.
11. Turtle, C.J. Hart, D.N.J. (2004) Dendritic cells in tumor immunology and immunotherapy. Current Drug Targets, 5, 17 39.
12. Vulink, A., Radford, K.J., Melief, C. Hart, D.N. (2008) Dendritic cells in cancer immunotherapy. Advances in Cancer Research, 99, 363 407.